San Diego, CA, United States of America

Mary Kopke Wloch

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 152(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: An Overview of Inventor Mary Kopke Wloch

Introduction

Mary Kopke Wloch is a distinguished inventor based in San Diego, CA, known for her significant contributions to the field of biotechnology. With a total of nine patents to her name, she has made impactful advancements, particularly in developing vaccines for viral infections.

Latest Patents

One of her latest inventions is focused on codon-optimized polynucleotide-based vaccines against human cytomegalovirus (HCMV) infection. This innovative approach involves plasmids that operably encode HCMV antigens, modified for enhanced translation in human and other mammalian cells. The invention includes antigens such as pp65, glycoprotein B (gB), and IE1, alongside their fragments, variants, or derivatives. Additionally, the invention outlines methods for inducing an immune response to HCMV by delivering a plasmid encoding these optimized antigens, as well as pharmaceutical compositions with adjuvants and immune modulators.

Another prominent patent includes a composition for an influenza virus vaccine, enhancing the immune response in individuals at risk of infection. This invention involves the administration of polynucleotides encoding influenza virus proteins, combined with immunogenic epitopes, ensuring a robust immune reaction against the virus.

Career Highlights

Mary Wloch has developed her career further by being associated with Vical Incorporated, where her expertise in biotechnology and vaccine development has shone through. Her innovative work continues to address pressing health issues and contribute to the advancement of immunology.

Collaborations

Throughout her career, Mary Wloch has collaborated with other notable professionals, including Andrew John Geall and Gary G. Hermanson. These collaborations have likely amplified her research capabilities and opened avenues for innovative solutions in vaccine development.

Conclusion

Mary Kopke Wloch's remarkable contributions to vaccine technology highlight her as a leading inventor. Her ongoing work in developing effective vaccines against HCMV and influenza virus showcases her commitment to public health and scientific advancement. As her research continues to evolve, her impact on the medical and scientific communities is undeniable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…